Fujifilm Biotechnologies has landed another major deal for its massive Holly Springs facility that will come online this year.

Brown University has struck a deal with the Trump administration to restore about $510 million in frozen federal research funds in exchange for various concessions but no payment, officials announced ...

Madrigal Pharmaceuticals Inc.’s long-awaited business development pact became reality by way of an exclusive global license agreement that could be worth more than $2 billion with CSPC Pharmaceutical ...

Discover Equitable Holdings' Q2 2025 insights, including $2B capital release, strong growth across segments, & plans for $500M in share buybacks.

New Jersey announces $2B forever chemical deal with DuPont companies By Ry Rivard | 08/04/2025 12:08 PM EDT It’s the largest such environmental settlement by a single state, officials said.

Northwell’s plan to build a new medical tower at Lenox Hill Hospital on the Upper East Side is headed for a key vote on Wednesday that will determine whether the project moves forward. The ...

GSK signed a 12-asset licensing deal with Hengrui. Generic erosion on Vyvanse pulled back Takeda. Celltrion plans to buy a large U.S. facility.

Madrigal is paying $120 million upfront for a preclinical GLP-1 agonist the biopharma plans to pair with its fatty liver disease med Rezdiffra.

The proposed CyberArk acquisition will enable Palo Alto Networks to make identity security a core pillar of its multiplatform strategy.

Leidos previously worked with the FBI to improve NGI’s fingerprint identification accuracy to over 99.6 percent.

Read the full Earnings Call Transcript Equitable outlines $2B cash generation target for 2027 as reinsurance deal unlocks capital© Provided by Seeking Alpha ...